Brief: Precision Biosciences To Receive Upfront Payment, Upon Commercialization By Caribou, Royalties On Sales Of Licensed Products
20/02/2024 12:17
Feb 20 (Reuters) - Precision BioSciences Inc DTIL.O :
* PRECISION BIOSCIENCES ANNOUNCES NON-EXCLUSIVE PATENT
LICENSE
AGREEMENT WITH CARIBOU BIOSCIENCES
* PRECISION BIOSCIENCES-UNDER AGREEMENT, CO TO RECEIVE
UPFRONT
PAYMENT, UPON COMMERCIALIZATION BY CARIBOU, ROYALTIES ON NET
SALES OF LICENSED PRODUCTS
Source text for Eikon: ID:nBw9ZQnGja
Further company coverage: DTIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precision Biosciences
See all newsPrecision BioSciences Inc reports results for the quarter ended June 30 - Earnings Summary
Precision BioSciences Q2 net loss widens on warrant liability charge
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Precision Biosciences - Enters First Amendment To Loan And Security Agreement With Banc Of California - SEC Filing